carbapenems has been researched along with rhamnetin in 2 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (rhamnetin) | Trials (rhamnetin) | Recent Studies (post-2010) (rhamnetin) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 80 | 0 | 49 |
| Protein | Taxonomy | carbapenems (IC50) | rhamnetin (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 2.7 | |
| ELAV-like protein 3 | Homo sapiens (human) | 1.2 | |
| Inositol hexakisphosphate kinase 2 | Homo sapiens (human) | 1.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, M; Kim, Y; Krishnan, M; Lee, H; Yoon, YK | 1 |
| Chaudhary, SC; Kim, B; Kim, M; Kim, Y | 1 |
2 other study(ies) available for carbapenems and rhamnetin
| Article | Year |
|---|---|
Rhamnetin, a Natural Flavonoid, Ameliorates Organ Damage in a Mouse Model of Carbapenem-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Carbapenems; Disease Models, Animal; Escherichia coli; Flavonoids; Mice; Microbial Sensitivity Tests; Sepsis | 2022 |
Protective Effects of Rhamnetin in Carbapenem-Resistant
Topics: Acinetobacter baumannii; Animals; Anti-Bacterial Agents; Carbapenems; Cytokines; Lipopolysaccharides; Mice; Microbial Sensitivity Tests; Reactive Oxygen Species; Sepsis; Shock, Septic; Toll-Like Receptor 4 | 2023 |